Sana Biotechnology Funding: $700M Raised, IPO (2020)
Sana Biotechnology is based in Seattle, WA. It has raised $700M in total funding. Latest round: IPO.
Sana Biotechnology funding overview
Sana Biotechnology is based in Seattle, WA. Sana Biotechnology has raised $700M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in June 2020. The round record for Sana Biotechnology runs through 2020; nothing later has been disclosed. Investors on record include Flagship Pioneering, ARCH Venture Partners, F-Prime Capital, Canada Pension Plan Investment Board, Baillie Gifford, Alaska Permanent Fund and 5 others. 11 distinct backers are named across the disclosed rounds.
Sana Biotechnology has raised $700M in total disclosed funding across the rounds on record.
Who has invested in Sana Biotechnology?
Flagship Pioneering, ARCH Venture Partners, F-Prime Capital, Canada Pension Plan Investment Board, Baillie Gifford, Alaska Permanent Fund are named among the investors backing Sana Biotechnology.
What was the latest Sana Biotechnology funding round?
The most recent disclosed round is an IPO, announced in June 2020.
Where is Sana Biotechnology based?
Sana Biotechnology is based in Seattle, WA.
When did Sana Biotechnology last raise?
The last disclosed Sana Biotechnology round closed in June 2020 at IPO.
Totals shown for Sana Biotechnology aggregate every disclosed round on file. To see how that compares, browse the companies in Seattle and the investors behind them below.
